Table 1.
Time course of heart rate and mean arterial pressure
| HR (bpm) | Baseline 1 | Ringer 7.5 min | Ringer 22.5 min | Ringer 37.5 min | Ringer 52.5 min | Baseline 2 | Parg 7.5 min | Parg 22.5 min | Parg 37.5 min | Parg 52.5 min | Parg 67.5 min | Parg 82.5 min |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fluo + Parg | 342 ± 40 | 349 ± 36 | 352 ± 35 | 353 ± 35 | 352 ± 33 | 352 ± 33 | 351 ± 31 | 349 ± 31 | 348 ± 31 | 349 ± 30 | 350 ± 31 | 350 ± 31 |
| D22 + Parg | 344 ± 26 | 351 ± 24 | 355 ± 20 | 354 ± 22 | 353 ± 23 | 351 ± 24 | 348 ± 22 | 346 ± 20 | 346 ± 19 | 347 ± 18 | 349 ± 18 | 349 ± 19 |
| Fluo + D22 + Parg | 341 ± 25 | 348 ± 25 | 352 ± 23 * | 354 ± 22 * | 354 ± 22 * | 353 ± 22 * | 350 ± 21 | 348 ± 20 | 347 ± 21 | 346 ± 23 | 347 ± 24 | 347 ± 25 |
| MABP (mmHg) | Baseline 1 | Ringer 7.5 min | Ringer 22.5 min | Ringer 37.5 min | Ringer 52.5 min | Baseline 2 | Parg 7.5 min | Parg 22.5 min | Parg 37.5 min | Parg 52.5 min | Parg 67.5 min | Parg 82.5 min |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fluo + Parg | 95 ± 27 | 96 ± 24 | 97 ± 22 | 95 ± 19 | 94 ± 18 | 94 ± 20 | 92 ± 17 | 91 ± 16 | 91 ± 16 | 91 ± 15 | 92 ± 15 | 92 ± 14 |
| D22 + Parg | 99 ± 18 | 99 ± 17 | 99 ± 15 | 96 ± 16 | 94 ± 16 | 92 ± 16 | 90 ± 16* | 89 ± 14* | 89 ± 14* | 89 ± 14* | 90 ± 14* | 90 ± 13* |
| Fluo + D22 + Parg | 99 ± 23 | 99 ± 19 | 98 ± 18 | 97 ± 15 | 96 ± 15 | 94 ± 14 | 91 ± 13 | 90 ± 13 | 88 ± 13* | 88 ± 14* | 89 ± 15 | 89 ± 14 |
Values are shown in mean ± SD (n = 7). Effects of local administration of fluoxetine (Fluo), decynium-22 (D22), and Fluo + D22 co-administered with pargyline (Parg) on heart rate (HR) and mean arterial blood pressure (MABP) were compared by one-way repeated measures ANOVA followed by Tukey's multiple comparison tests
*p < 0.05 vs baseline 1